Expression of Interleukin-1 and Interleukin-1 Receptors Type 1 and Type 2 in Hodgkin Lymphoma.

about

New developments in the pathology of malignant lymphoma. A review of the literature published from September 2015–December 2015 Role of polymorphisms in genes that encode cytokines and Helicobacter pylori virulence factors in gastric carcinogenesis

P2860

Q26767492-C370216D-58BA-446A-AC1A-DDD9560067D5 Q58739958-96289FCB-B06B-4B90-A8C8-D8129F447581

P2860

Expression of Interleukin-1 and Interleukin-1 Receptors Type 1 and Type 2 in Hodgkin Lymphoma.

Item

http://www.wikidata.org/entity/Q35788358

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Expression of Interleukin-1 an ...... nd Type 2 in Hodgkin Lymphoma.

@ast

Expression of Interleukin-1 an ...... nd Type 2 in Hodgkin Lymphoma.

@en

type

Item

label

Expression of Interleukin-1 an ...... nd Type 2 in Hodgkin Lymphoma.

@ast

Expression of Interleukin-1 an ...... nd Type 2 in Hodgkin Lymphoma.

@en

prefLabel

Expression of Interleukin-1 an ...... nd Type 2 in Hodgkin Lymphoma.

@ast

Expression of Interleukin-1 an ...... nd Type 2 in Hodgkin Lymphoma.

@en

P1476

Expression of Interleukin-1 an ...... nd Type 2 in Hodgkin Lymphoma.

@en

P2093

Elisabeth Oelmann

http://www.w3.org/2001/XMLSchema#string

Harald Stein

http://www.w3.org/2001/XMLSchema#string

Hermann Herbst

http://www.w3.org/2001/XMLSchema#string

Wolfgang E Berdel

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4

Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist

The soluble form of IL-1 receptor accessory protein enhances the ability of soluble type II IL-1 receptor to inhibit IL-1 action

Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4

The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness

Interleukin 1 signaling occurs exclusively via the type I receptor

PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma

Type 2 cytokines predominate in the human CD4(+) T-lymphocyte response to Epstein-Barr virus nuclear antigen 1.

Defective interleukin (IL)-18-mediated natural killer and T helper cell type 1 responses in IL-1 receptor-associated kinase (IRAK)-deficient mice

Molecular mechanisms and Th1/Th2 pathways in corticosteroid regulation of cytokine production.

P304

e0138747

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0138747

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282277779

http://www.w3.org/2001/XMLSchema#string

P698

26406983

http://www.w3.org/2001/XMLSchema#string

P932

4583993

http://www.w3.org/2001/XMLSchema#string

Expression of Interleukin-1 and Interleukin-1 Receptors Type 1 and Type 2 in Hodgkin Lymphoma.

about

P2860

P2860

Expression of Interleukin-1 and Interleukin-1 Receptors Type 1 and Type 2 in Hodgkin Lymphoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932